analiza aiqbench

INmune Bio and Quantum Computing Inc. are leveraging QCi's Dirac-3S quantum optimization machine to analyze biomedical datasets for identifying new therapeutic indications for their Alzheimer's treatment, XPro. This partnership marks a significant commercial milestone as the first engagement of its kind for QCi in the pharmaceutical sector, directly integrating quantum algorithms with AI to prioritize high-potential disease targets. The initiative aims to validate whether quantum methods can uncover complex biological relationships more effectively than conventional statistical or machine-learning approaches.